Kathleen Goetz
CIK: 0001896369
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AUPH
Aurinia Pharmaceuticals Inc.
Director
Discretionary Trading P&L
Holdings
About Goetz Kathleen
Goetz Kathleen (SEC CIK 0001896369) files insider reports with the SEC as Director of Aurinia Pharmaceuticals Inc. (AUPH).
Signal8 holds 3 ownership filings by Goetz Kathleen (1 Form 3, 2 Form 4), filed between May 16, 2025 and Jun 8, 2026. Those filings report 2 transactions, from May 16, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goetz Kathleen's filings is in EDMONTON.
Recent filings by Goetz Kathleen
Other insiders filing for Aurinia Pharmaceuticals Inc. (AUPH)
- Robertson Stephen P., Chief Legal Officer
- Johnson Craig A, Director
- Nova Tina Susan, Director
- Bailey Jeffrey Allen, Director
- TANG KEVIN, Chief Executive Officer
- Hearne Michael S, Chief Financial Officer